Cargando…
Are we responding effectively to bone mineral density loss and fracture risks in people with epilepsy?
OBJECTIVE: A 2007 study performed at Montefiore Medical Center (Bronx, NY) identified high prevalence of reduced bone density in an urban population of patients with epilepsy and suggested that bone mineralization screenings should be regularly performed for these patients. We conducted a long‐term...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7278536/ https://www.ncbi.nlm.nih.gov/pubmed/32524049 http://dx.doi.org/10.1002/epi4.12392 |
_version_ | 1783543354430062592 |
---|---|
author | Miller, Amitai S. Ferastraoaru, Victor Tabatabaie, Vafa Gitlevich, Tatyana R. Spiegel, Rebecca Haut, Sheryl R. |
author_facet | Miller, Amitai S. Ferastraoaru, Victor Tabatabaie, Vafa Gitlevich, Tatyana R. Spiegel, Rebecca Haut, Sheryl R. |
author_sort | Miller, Amitai S. |
collection | PubMed |
description | OBJECTIVE: A 2007 study performed at Montefiore Medical Center (Bronx, NY) identified high prevalence of reduced bone density in an urban population of patients with epilepsy and suggested that bone mineralization screenings should be regularly performed for these patients. We conducted a long‐term follow‐up study to determine whether bone mineral density (BMD) loss, osteoporosis, and fractures have been successfully treated or prevented. METHODS: In the current study, patients from the 2007 study who had two dual‐energy absorptiometry (DXA) scans performed at least 5 years apart were analyzed. The World Health Organization (WHO) criteria to diagnose patients with osteopenia or osteoporosis were used, and each patient's probability of developing fractures was calculated with the Fracture Risk Assessment Tool (FRAX). RESULTS: The median time between the first and second DXA scans for the 81 patients analyzed was 9.4 years (range 5‐14.7). The median age at the first DXA scan was 41 years (range 22‐77). Based on WHO criteria, 79.0% of patients did not have worsening of bone density, while 21.0% had new osteopenia or osteoporosis; many patients were prescribed treatment for bone loss. Older age, increased duration of anti‐epileptic drug (AED) usage, and low body mass index (BMI) were risk factors for abnormal BMDs. Based on the first DXA scan, the FRAX calculator estimated that none of the patients in this study had a 10‐year risk of more than 20% for developing major osteoporotic fracture (hip, spine, wrist, or humeral fracture). However, in this population, 11 patients (13.6%) sustained a major osteoporotic fracture after their first DXA scan. SIGNIFICANCE: Despite being routinely screened and frequently treated for bone mineral density loss and fracture prevention, many patients with epilepsy suffered new major osteoporotic fractures. This observation is especially important as persons with epilepsy are at high risk for falls and traumas. |
format | Online Article Text |
id | pubmed-7278536 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-72785362020-06-09 Are we responding effectively to bone mineral density loss and fracture risks in people with epilepsy? Miller, Amitai S. Ferastraoaru, Victor Tabatabaie, Vafa Gitlevich, Tatyana R. Spiegel, Rebecca Haut, Sheryl R. Epilepsia Open Full‐length Original Research OBJECTIVE: A 2007 study performed at Montefiore Medical Center (Bronx, NY) identified high prevalence of reduced bone density in an urban population of patients with epilepsy and suggested that bone mineralization screenings should be regularly performed for these patients. We conducted a long‐term follow‐up study to determine whether bone mineral density (BMD) loss, osteoporosis, and fractures have been successfully treated or prevented. METHODS: In the current study, patients from the 2007 study who had two dual‐energy absorptiometry (DXA) scans performed at least 5 years apart were analyzed. The World Health Organization (WHO) criteria to diagnose patients with osteopenia or osteoporosis were used, and each patient's probability of developing fractures was calculated with the Fracture Risk Assessment Tool (FRAX). RESULTS: The median time between the first and second DXA scans for the 81 patients analyzed was 9.4 years (range 5‐14.7). The median age at the first DXA scan was 41 years (range 22‐77). Based on WHO criteria, 79.0% of patients did not have worsening of bone density, while 21.0% had new osteopenia or osteoporosis; many patients were prescribed treatment for bone loss. Older age, increased duration of anti‐epileptic drug (AED) usage, and low body mass index (BMI) were risk factors for abnormal BMDs. Based on the first DXA scan, the FRAX calculator estimated that none of the patients in this study had a 10‐year risk of more than 20% for developing major osteoporotic fracture (hip, spine, wrist, or humeral fracture). However, in this population, 11 patients (13.6%) sustained a major osteoporotic fracture after their first DXA scan. SIGNIFICANCE: Despite being routinely screened and frequently treated for bone mineral density loss and fracture prevention, many patients with epilepsy suffered new major osteoporotic fractures. This observation is especially important as persons with epilepsy are at high risk for falls and traumas. John Wiley and Sons Inc. 2020-04-14 /pmc/articles/PMC7278536/ /pubmed/32524049 http://dx.doi.org/10.1002/epi4.12392 Text en © 2020 The Authors. Epilepsia Open published by Wiley Periodicals Inc. on behalf of International League Against Epilepsy. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Full‐length Original Research Miller, Amitai S. Ferastraoaru, Victor Tabatabaie, Vafa Gitlevich, Tatyana R. Spiegel, Rebecca Haut, Sheryl R. Are we responding effectively to bone mineral density loss and fracture risks in people with epilepsy? |
title | Are we responding effectively to bone mineral density loss and fracture risks in people with epilepsy? |
title_full | Are we responding effectively to bone mineral density loss and fracture risks in people with epilepsy? |
title_fullStr | Are we responding effectively to bone mineral density loss and fracture risks in people with epilepsy? |
title_full_unstemmed | Are we responding effectively to bone mineral density loss and fracture risks in people with epilepsy? |
title_short | Are we responding effectively to bone mineral density loss and fracture risks in people with epilepsy? |
title_sort | are we responding effectively to bone mineral density loss and fracture risks in people with epilepsy? |
topic | Full‐length Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7278536/ https://www.ncbi.nlm.nih.gov/pubmed/32524049 http://dx.doi.org/10.1002/epi4.12392 |
work_keys_str_mv | AT milleramitais arewerespondingeffectivelytobonemineraldensitylossandfracturerisksinpeoplewithepilepsy AT ferastraoaruvictor arewerespondingeffectivelytobonemineraldensitylossandfracturerisksinpeoplewithepilepsy AT tabatabaievafa arewerespondingeffectivelytobonemineraldensitylossandfracturerisksinpeoplewithepilepsy AT gitlevichtatyanar arewerespondingeffectivelytobonemineraldensitylossandfracturerisksinpeoplewithepilepsy AT spiegelrebecca arewerespondingeffectivelytobonemineraldensitylossandfracturerisksinpeoplewithepilepsy AT hautsherylr arewerespondingeffectivelytobonemineraldensitylossandfracturerisksinpeoplewithepilepsy |